World Cancer Day 2025: International Journal of Cancer
The International Journal of Cancer is a cancer journal from the Union for International Cancer Control covering experimental and clinical cancer research.
Related Articles
Adjuvant Chemotherapy After Resection of Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX
This cohort study investigates the association of adjuvant chemotherapy following resection of pancreatic adenocarcinoma after preoperative FOLFIRINOX in full or modified dosing with overall survival,…
Maintenance Galinpepimut-S Appears Effective and Safe in AML in Second CR
Galinpepimut-S demonstrated early efficacy signals in patients with acute myeloid leukemia in second complete remission or later.
Tagitanlimab Plus Chemotherapy Receives Chinese Approval for Recurrent/Metastatic Nasopharyngeal Cancer
Tagitanlimab received marketing authorization from the Chinese NMPA for use with cisplatin and gemcitabine for patients with recurrent or metastatic NPC.
Case Study4
Wolters Kluwer (“we” or “us”) wants to inform you about the ways we process your personal information. In this Privacy & Cookie Notice we explain…
Oncology Experts Preview Top Abstracts to be Shared at 2025 ASCO GI
Tanios S. Bekaii-Saab, MD, and Yelena Y. Janjigian, MD, preview top presentations from this yearβs Gastrointestinal Cancers Symposium.
Spontaneous coronary artery dissection (SCAD): A contemporary review
Spontaneous Coronary Artery Dissection (SCAD) is an increasingly recognized cause of myocardial infarction that most frequently affects younger women, making it an important cause of…
Association of mental health treatment receipt with cancer screening among US adults with a history of anxiety or depression
Adults with a history of depression or anxiety who lacked mental health treatment in the past year were significantly less likely to be up-to-date with…
Immunotherapy for pediatric osteosarcoma with lung metastases after resection shows positive data – The Cancer Letter
OS Therapies Inc. announced positive data from a phase IIb clinical trial (NCT04974008) of OST-HER2 (OST31-164)βthe companyβs HER2-targeted immunotherapy candidate in the rare pediatric-designated indication…
The common VTE-protective G haplotype of F5 increases factor V-short, TFPI function, and risk of bleeding
Key PointsIndividuals homozygous for the F5 G haplotype (F5-G/G) have increased alternative F5 splicing that leads to increased plasma FV-short levels.F5-G
